These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15293983)

  • 1. Prospects for inhibitors of protein tyrosine phosphatase 1B as antidiabetic drugs.
    Hooft van Huijsduijnen R; Sauer WH; Bombrun A; Swinnen D
    J Med Chem; 2004 Aug; 47(17):4142-6. PubMed ID: 15293983
    [No Abstract]   [Full Text] [Related]  

  • 2. Protein tyrosine phosphatase 1B inhibitors for the treatment of type 2 diabetes and obesity: recent advances.
    Harley EA; Levens N
    Curr Opin Investig Drugs; 2003 Oct; 4(10):1179-89. PubMed ID: 14649209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein tyrosine phosphatase 1B inhibitors for diabetes.
    Johnson TO; Ermolieff J; Jirousek MR
    Nat Rev Drug Discov; 2002 Sep; 1(9):696-709. PubMed ID: 12209150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel "second-generation" approaches for the control of type 2 diabetes.
    Rotella DP
    J Med Chem; 2004 Aug; 47(17):4111-2. PubMed ID: 15293978
    [No Abstract]   [Full Text] [Related]  

  • 5. [Does inhibition of tyrosine phosphatase 1B protect from obesity and type 2 diabetes?].
    Ukkola O; Santaniemi M
    Duodecim; 2002; 118(18):1857-62. PubMed ID: 12422667
    [No Abstract]   [Full Text] [Related]  

  • 6. Protein tyrosine phosphatase 1B as a target for the treatment of impaired glucose tolerance and type II diabetes.
    Liu G; Trevillyan JM
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1608-16. PubMed ID: 12476961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of protein tyrosine phosphatase 1B by ursane-type triterpenes isolated from Symplocos paniculata.
    Na M; Yang S; He L; Oh H; Kim BS; Oh WK; Kim BY; Ahn JS
    Planta Med; 2006 Feb; 72(3):261-3. PubMed ID: 16534732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in protein tyrosine phosphatase 1B inhibitors.
    Taylor SD; Hill B
    Expert Opin Investig Drugs; 2004 Mar; 13(3):199-214. PubMed ID: 15013940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting protein tyrosine phosphatase to enhance insulin action for the potential treatment of diabetes.
    Kasibhatla B; Wos J; Peters KG
    Curr Opin Investig Drugs; 2007 Oct; 8(10):805-13. PubMed ID: 17907056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the development of small molecule inhibitors of PTP1B for the treatment of insulin resistance and type 2 diabetes.
    Tobin JF; Tam S
    Curr Opin Drug Discov Devel; 2002 Jul; 5(4):500-12. PubMed ID: 12197308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein tyrosine phosphatase 1B inhibitors as antidiabetic agents - A brief review.
    Verma M; Gupta SJ; Chaudhary A; Garg VK
    Bioorg Chem; 2017 Feb; 70():267-283. PubMed ID: 28043717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity.
    Navarrete-Vazquez G; Paoli P; León-Rivera I; Villalobos-Molina R; Medina-Franco JL; Ortiz-Andrade R; Estrada-Soto S; Camici G; Diaz-Coutiño D; Gallardo-Ortiz I; Martinez-Mayorga K; Moreno-Díaz H
    Bioorg Med Chem; 2009 May; 17(9):3332-41. PubMed ID: 19362487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological profiles of a novel protein tyrosine phosphatase 1B inhibitor, JTT-551.
    Fukuda S; Ohta T; Sakata S; Morinaga H; Ito M; Nakagawa Y; Tanaka M; Matsushita M
    Diabetes Obes Metab; 2010 Apr; 12(4):299-306. PubMed ID: 20380650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vanadium salts as insulin substitutes: mechanisms of action, a scientific and therapeutic tool in diabetes mellitus research.
    Sekar N; Li J; Shechter Y
    Crit Rev Biochem Mol Biol; 1996 Dec; 31(5-6):339-59. PubMed ID: 8994801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of protein tyrosine phosphatase 1B as a potential treatment of diabetes and obesity.
    Pei Z; Liu G; Lubben TH; Szczepankiewicz BG
    Curr Pharm Des; 2004; 10(28):3481-504. PubMed ID: 15579047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and structure-activity relationships of novel sulfonamides as potent PTP1B inhibitors.
    Holmes CP; Li X; Pan Y; Xu C; Bhandari A; Moody CM; Miguel JA; Ferla SW; De Francisco MN; Frederick BT; Zhou S; Macher N; Jang L; Irvine JD; Grove JR
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4336-41. PubMed ID: 16046123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycemic effect of Astragalus polysaccharide and its effect on PTP1B.
    Wu Y; Ou-Yang JP; Wu K; Wang Y; Zhou YF; Wen CY
    Acta Pharmacol Sin; 2005 Mar; 26(3):345-52. PubMed ID: 15715932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular PTPs: current developments and challenges for exploitation in Type 2 diabetes-associated vascular dysfunction.
    Popov D
    Biochem Biophys Res Commun; 2009 Nov; 389(1):1-4. PubMed ID: 19715673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 2-aryl-naphtho[1,2-d]oxazole derivatives as potential PTP-1B inhibitors showing antihyperglycemic activities.
    Kumar A; Ahmad P; Maurya RA; Singh AB; Srivastava AK
    Eur J Med Chem; 2009 Jan; 44(1):109-16. PubMed ID: 18436346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of triazole-linked beta-C-glycosyl dimers as inhibitors of PTP1B.
    Lin L; Shen Q; Chen GR; Xie J
    Bioorg Med Chem; 2008 Nov; 16(22):9757-63. PubMed ID: 18922697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.